CN1246031C - Chinese patent drug-Fuyan capsdule for treating chronic pelvic inflammation - Google Patents
Chinese patent drug-Fuyan capsdule for treating chronic pelvic inflammation Download PDFInfo
- Publication number
- CN1246031C CN1246031C CN 03111747 CN03111747A CN1246031C CN 1246031 C CN1246031 C CN 1246031C CN 03111747 CN03111747 CN 03111747 CN 03111747 A CN03111747 A CN 03111747A CN 1246031 C CN1246031 C CN 1246031C
- Authority
- CN
- China
- Prior art keywords
- inflammation
- chronic pelvic
- chinese patent
- curing
- present
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The present invention discloses a Chinese patent medicament for curing chronic pelvic inflammation, which relates to a capsule for woman inflammation. Honeysuckle, weeping forsythia, glabrous greenbrier rhizome, phellodendron, patrinia, sargentgloryvine stem, spreading hedyotis herb, cortex ailanthi, yam rhizome, red peony roots, peach kernel, zedoary and red sage roots are used as raw materials; the 13 types of medicaments are immersed and decocted for 2 hours by adding water and are filtered, and filter residue is repeatedly decocted for twice; filter liquid is merged and is concentrated to form thick paste; and the thick paste is dried and pulverized to form fine powder and is loaded into capsules for standby. The present invention has preferable functions of inhibiting inflammation and alleviating the sequelae of the inflammation, and has a favorable curative effect during the process of curing the chronic pelvic inflammation. The present invention mainly cures the inflammation of a genital organ for females, and is mainly used for curing the chronic pelvic inflammation, endometritis, annexitis, inflammation of connective tissues, etc.
Description
One, technical field
The present invention relates to a kind of pharmaceutical composition for the treatment of chronic pelvic inflammatory disease, particularly relating to a kind of is the Chinese patent medicine of the treatment chronic pelvic inflammatory disease made of raw material with the vegetable Chinese herbal medicine.
Two, background technology
Chronic pelvic inflammatory disease comprises endometritis, adnexitis and inflammation of pelvic connective tissue, is that the woman expects commonly encountered diseases, frequently-occurring disease, also is one of difficult and complicated illness, and a tree name statistics accounts for more than 60% of adult women.Because acute pelvic inflammatory disease treatment is untimely, not thorough, or patient's body constitution is relatively poor, or the get the brush-off delay or develop of light-duty subacute pathological changes forms.Modern medicine is thought, because patient's premorbid existence self metaboilic level is low, resistance against diseases obviously goes down, when meeting aerobe or anaerobic infection, make inflammation to palace body, the other diffusion in palace, and then cause the inflammation of adnexa and pelvic cavity connective tissue, certainly exist local patholoic change and produce pathological changes such as adhesion, atrophy, fibrosis.Aspect treatment, doctor trained in Western medicine adopts antibiosis to have certain effect, but prolonged application not only directly reduces the infection curative effect, also can cause bacterial resistance, untoward reaction also can occur and add heavy patient's financial burden.
Primary disease is under the jurisdiction of motherland's medical science " leukorrheal diseases ", " stomachache ", " abdominal mass ", " menoxenia " and categories such as " infertile ".It is generally acknowledged how to fall ill owing to damp and hot heresy injures conception vessel, " element is asked the bone empty talk " just once pointed out: " conception vessel is for sick, and woman's leukorrhagia gathers ".Ancient Chinese medicine doctor is not interrupted research to this disease always, the tradition prescription has that yihuang decoction, Erhuang three are white to loose etc., recently the usefulness that has of scholar is from intending prescription (comprising decoction, Chinese patent medicine), what also have treats with methods such as Chinese traditional medicine wet compress, herbal enema, physical therapys, these method curative effects are all not really definite, recurrence easily, and what have is also cumbersome, patient is difficult to adhere to use, can not be widely at clinical application.
Three, summary of the invention
Purpose of the present invention can overcome above-mentioned deficiency exactly, and a kind of good effect be provided, be difficult for recurring, have no side effect, cheap, the Chinese patent medicine of being convenient to the treatment chronic pelvic inflammatory disease of using and carrying.
The technical scheme that the present invention takes is basis modal " damp and hot blood stasis " card clinically, adopts clearing away heat and eliminating dampness, activating blood and resolving stasis and treating, is that the medicine card conforms to the bone joints-most important juncture of hitting.The modern Chinese medicine pharmacological research proves that clearing away heat and eliminating dampness class medicine can reduce capillary permeability, and minimizing is oozed out, and the acceleration inflammation absorbs, the further hypertrophy of prevention connective tissue, and drug for invigorating blood circulation and eliminating stasis can change blood flow, promotes the softening and absorption of proliferative lesion.
The medicine of the Chinese patent medicine of treatment chronic pelvic inflammatory disease is formed: used medical material part by weight is Flos Lonicerae 15～18g, Fructus Forsythiae 12～15g, Rhizoma Smilacis Glabrae 15～30g, Cortex Phellodendri 12～15g, Herba Patriniae 15～30g, Caulis Sargentodoxae 12～15g, Herba Hedyotidis Diffusae 15～30g, Cortex Ailanthi 15～30g, Bi 15～30g, Radix Paeoniae Rubra 12～15g, Semen Persicae 12～15g, Rhizoma Curcumae 10～12g, Radix Salviae Miltiorrhizae 12～30g.
Scorching capsular optimum weight (gram) proportioning of woman of the present invention is: Flos Lonicerae 15g, Fructus Forsythiae 12g, Rhizoma Smilacis Glabrae 15g, Cortex Phellodendri 12g, Herba Patriniae 15g, Caulis Sargentodoxae 12g, Herba Hedyotidis Diffusae 15g, Cortex Ailanthi 15g, Bi 15g, Radix Paeoniae Rubra 12g, Semen Persicae 12g, Rhizoma Curcumae 10g, Radix Salviae Miltiorrhizae 12g.
Above-mentioned each component is made preparation method of the present invention is: get above 13 flavor medicines and add water to submerge decoction 2 hours, filter, filtering residue repeats to decoct 2 times, and merging filtrate is condensed into thick paste, and oven dry is ground into fine powder and incapsulates standby.
Specification: 0.4g * 60/bottle.
Usage and dosage: each 6～8, every day 3 times, ante cibum is oral or follow the doctor's advice.
Four, beneficial effect
The present invention has inflammation-inhibiting preferably and the effect of the sequela that reduces inflammation, and in the process of treatment chronic pelvic inflammatory disease, good therapeutic effect is arranged.Cure mainly the female sex organ inflammation, be mainly used in chronic pelvic inflammatory disease, endometritis, adnexitis and inflammation of connective tissue etc.
See Appendix 1 (experiment and the clinical research technical report of the scorching capsule for treating chronic pelvic inflammatory disease of woman)
See Appendix 2 (the scorching capsule for treating chronic pelvic inflammatory disease of woman testing datas)
Five, embodiment
The scorching capsule of woman of the present invention takes by weighing raw material (kilogram) by following proportioning, and the amount of getting of various medical materials is: Flos Lonicerae 15g, Fructus Forsythiae 12g, Rhizoma Smilacis Glabrae 15g, Cortex Phellodendri 12g, Herba Patriniae 15g, Caulis Sargentodoxae 12g, Herba Hedyotidis Diffusae 15g, Cortex Ailanthi 15g, Bi 15g, Radix Paeoniae Rubra 12g, Semen Persicae 12g, Rhizoma Curcumae 10g, Radix Salviae Miltiorrhizae 12g.Preparation method is: get above 13 flavor medicines and add water to submerge decoction 2 hours, filter, filtering residue repeats to decoct 2 times, and merging filtrate is condensed into thick paste, and oven dry is ground into fine powder and incapsulates standby.Be assigned randomly to treatment group (A) or matched group (B) by screening qualified case, the treatment group is totally 100 examples, and matched group is totally 50 examples.The treatment group is taken the scorching capsule of woman, every day 3 times, each 6～8; Matched group is taken FULE CHONGJI, every day 2 times, each 9g.It is the course of treatment that two medicines are all obeyed one month, and carries out the inspection of health giving quality and safety detection before and after taking medicine, through clinical observation, treatment group total effective rate is 93.75%, and the matched group total effective rate is 75.84%, and the treatment group is apparently higher than matched group, confirmed this medication effect significantly, had no adverse reaction.The present invention of experimental result proof has inflammation-inhibiting, the sequela that reduces inflammation and obviously analgesic effect preferably, and animal acute toxicity experiment is observed oral safety.Evident in efficacy, have no side effect; Practical, cheap, the medicine source is wide, and it is easy to carry to take safety, for the treatment of chronic pelvic inflammatory disease provides a new approach.
Claims (2)
1, a kind of Chinese patent medicine for the treatment of chronic pelvic inflammatory disease, it is characterized in that it being to be made by 13 flavor medical materials, its used medical material part by weight is Flos Lonicerae 15～18g, Fructus Forsythiae 12～15g, Rhizoma Smilacis Glabrae 15～30g, Cortex Phellodendri 12～15g, Herba Patriniae 15～30g, Caulis Sargentodoxae 12～15g, Herba Hedyotidis Diffusae 15～30g, Cortex Ailanthi 15～30g, Bi 15～30g, Radix Paeoniae Rubra 12～15g, Semen Persicae 12～15g, Rhizoma Curcumae 10～12g, Radix Salviae Miltiorrhizae 12～30g.
2, the Chinese patent medicine of treatment chronic pelvic inflammatory disease according to claim 1, wherein the weight proportion of each raw material is Flos Lonicerae 15g, Fructus Forsythiae 12g, Rhizoma Smilacis Glabrae 15g, Cortex Phellodendri 12g, Herba Patriniae 15g, Caulis Sargentodoxae 12g, Herba Hedyotidis Diffusae 15g, Cortex Ailanthi 15g, Bi 15g, Radix Paeoniae Rubra 12g, Semen Persicae 12g, Rhizoma Curcumae 10g, Radix Salviae Miltiorrhizae 12g.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN 03111747 CN1246031C (en) | 2003-01-18 | 2003-01-18 | Chinese patent drug-Fuyan capsdule for treating chronic pelvic inflammation |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN 03111747 CN1246031C (en) | 2003-01-18 | 2003-01-18 | Chinese patent drug-Fuyan capsdule for treating chronic pelvic inflammation |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN1517115A CN1517115A (en) | 2004-08-04 |
| CN1246031C true CN1246031C (en) | 2006-03-22 |
Family
ID=34283493
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN 03111747 Expired - Fee Related CN1246031C (en) | 2003-01-18 | 2003-01-18 | Chinese patent drug-Fuyan capsdule for treating chronic pelvic inflammation |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN1246031C (en) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1316991C (en) * | 2004-12-21 | 2007-05-23 | 中国农业科学院兰州畜牧与兽药研究所 | Chinese traditional medicine in use for treating endometritis of cow |
| CN101181599B (en) * | 2007-11-20 | 2010-06-23 | 浙江大学 | Chinese medicine composition for curing chronic pelvic inflammatory disease as well as application thereof |
| CN102302746B (en) * | 2011-09-20 | 2014-01-29 | 浙江大学 | Traditional Chinese medicine composition for treating pelvic inflammatory disease (PID) and application thereof |
| CN103099909A (en) * | 2013-01-25 | 2013-05-15 | 大连民族学院 | Retention enema for treating chronic pelvic inflammation |
| CN104367946A (en) * | 2014-11-06 | 2015-02-25 | 青岛恒波仪器有限公司 | Traditional Chinese medicine suppository for treating chronic endometritis and preparation method thereof |
| CN105596510A (en) * | 2016-01-15 | 2016-05-25 | 张帆 | Chinese patent medicine for treating miscellaneous gynecological diseases |
| CN106266258A (en) * | 2016-09-21 | 2017-01-04 | 张帆 | A kind of Chinese patent medicine for treating miscellaneous gynecological diseases |
-
2003
- 2003-01-18 CN CN 03111747 patent/CN1246031C/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| CN1517115A (en) | 2004-08-04 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN101518600B (en) | Chinese medicinal composition for treating bacterial or fungal dermatosis and preparation method thereof | |
| CN103520572A (en) | Traditional Chinese composition used for treating atopic dermatitis as well as preparation method of composition | |
| CN102697830A (en) | Pharmaceutical composition for preventing and treating menstrual disease and preparation method and application of composition | |
| CN104922543A (en) | Medicine composite for treating amenorrhea and preparation method thereof | |
| CN100406050C (en) | A Chinese traditional medicinal preparation for improving sub-health disease | |
| CN101897821B (en) | Granular preparation for promoting blood circulation, dredging collaterals and relieving pain and preparation method as well as detection method thereof | |
| CN102462827A (en) | Traditional Chinese medicinal powder formulation for treating postpartum mastitis of Boer goat | |
| CN1246031C (en) | Chinese patent drug-Fuyan capsdule for treating chronic pelvic inflammation | |
| CN102727779A (en) | Pharmaceutical composition for treating ovarian cysts and preparation method thereof | |
| CN102698207A (en) | Traditional Chinese medicine composition for treating hepatopathy and preparation method thereof | |
| CN102657736B (en) | Medicament composition for treating rheumatoid arthritis and preparation method of medicament composition | |
| CN102178781B (en) | Chinese medicine composition for treating scrotum eczema and preparation method thereof | |
| CN104623376B (en) | Be used for the treatment of prosopalgic medicine | |
| CN101390993B (en) | Traditional Chinese medicine for treating diabetic foot | |
| CN102416145A (en) | Chinese medicinal composition for treating menstrual disorder | |
| CN103142897B (en) | Medicine used after esophageal achalasia operation | |
| CN101850071A (en) | Chinese medicament for treating chronic nephritis | |
| CN101129584A (en) | Chinese medicine preparation for treating post partum hypogalactia | |
| CN101530593B (en) | Traditional Chinese medicine for treating diabetic numbness of extremities | |
| CN104208640A (en) | Traditional Chinese medicine composition for treating delayed menstrual cycle | |
| CN103494939A (en) | Traditional Chinese medicine for treating senile habitual constipation | |
| CN102526384A (en) | Medicament for treating rheumatism and preparation method thereof | |
| CN103142898B (en) | Preparation method of medicine used after esophageal achalasia operation | |
| CN101380414B (en) | Traditional Chinese medicine composition for treating gout and hyperuricemia and preparation method thereof | |
| CN101884747B (en) | Traditional Chinese medicine for treating chronic nephritis |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| C19 | Lapse of patent right due to non-payment of the annual fee | ||
| CF01 | Termination of patent right due to non-payment of annual fee |